Colon Polyps
Conditions
Interventions
AI-Assisted Group:The use of AMC to evaluate colonoscopy performance in the group assisted by the real-time feedback system with an external display.
Control group:The conventional colonoscopy group, examined with the AMC feedback system connected but its display disabled.
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.Voluntarily participate in the trial and provide signed informed consent. 2.Aged 18 to 85 years (inclusive), regardless of gender. 3.Have an indication for digestive endoscopy. 4.Able to communicate effectively with the investigator and comply with all trial requirements
Exclusion criteria
Exclusion criteria: 1.Presence of any contraindication to digestive endoscopy. 2.Patients at high risk of complications from endoscopy, such as unstable cardiac or pulmonary function, active bleeding, obstruction, or suspected gastrointestinal perforation. 3.Patients with severe psychiatric disorders. 4.Women who are pregnant or lactating. 5.Poor compliance, unwillingness, or inability to adhere to the trial protocol requirements. 6.Any other condition deemed by the investigator to render the patient unsuitable for trial participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adenoma Detection Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Withdrawal Time;Polyp Detection Rate;Safety Assessment;Detection rate of adenomas by size and location;Detection rate of polyps by size and location;Average number of adenomas detected per colonoscopy;Average number of polyps detected per colonoscopy;Safety evaluation: system stability and occurrence of adverse events (AEs/SAEs) in participants; | — |
Countries
China
Contacts
Public ContactLiu Ling
West China Hospital, Sichuan University
Outcome results
None listed